Novel Delivery Systems for Checkpoint Inhibitors

Checkpoint inhibition (CPI) therapies have been proven to be powerful clinical tools in treating cancers. FDA approvals and ongoing clinical development of checkpoint inhibitors for treatment of various cancers highlight the immense potential of checkpoint inhibitors as anti-cancer therapeutics. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamichhane, Purushottam, Deshmukh, Rahul, Brown, Julie A., Jakubski, Silvia, Parajuli, Priyanka, Nolan, Todd, Raja, Dewan, Badawy, Mary, Yoon, Thomas, Zmiyiwsky, Mark, Lamichhane, Narottam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789831/
https://www.ncbi.nlm.nih.gov/pubmed/31373327
http://dx.doi.org/10.3390/medicines6030074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789831/
https://www.ncbi.nlm.nih.gov/pubmed/31373327
http://dx.doi.org/10.3390/medicines6030074

Ejemplares similares